GSE213988 RRM2 knockdown 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE213988_RRM2 knockdown_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE213988_RRM2 knockdown_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE213988_RRM2 knockdown_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE213988_RRM2 knockdown_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H19 imprinted maternally expressed transcript

Gene

H3.3 histone A

Gene

cutA divalent cation tolerance like, pseudogene

Gene

metastasis associated lung adenocarcinoma transcript 1

Gene

high mobility group box 1 pseudogene 5

Gene

MT-ATP6 pseudogene 1

Gene

MT-ND2 pseudogene 28

Gene

C1RL antisense RNA 1

Gene

FSHD region gene 1 family member H, pseudogene

Gene

HOXC cluster antisense RNA 2

  • Gene

    H19 imprinted maternally expressed transcript



  • Gene

    cutA divalent cation tolerance like, pseudogene


  • Gene

    metastasis associated lung adenocarcinoma transcript 1


  • Gene

    high mobility group box 1 pseudogene 5


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    MT-ND2 pseudogene 28


  • Gene

    C1RL antisense RNA 1


  • Gene

    FSHD region gene 1 family member H, pseudogene


  • Gene

    HOXC cluster antisense RNA 2

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.